Pacer WealthShield ETF
Limited financial coverage for PWS.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Pacer Funds Trust - Pacer WealthShield ETF is an exchange traded fund launched and managed by Pacer Advisors, Inc. The fund invests in public equity and fixed income markets of the United States. It invests directly and through other funds to create its portfolio.
- IPO
- 2017
- HQ
- Malvern, PA, US
Get TickerSpark's AI analysis on PWS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $24.38M
- Div Yield
- 2.12%
- 52W High
- $33.83
- 52W Low
- $31.18
- 50D MA
- $32.83
- 200D MA
- $32.53
- Beta
- 0.72
- RSI (14)
- 50
- Avg Volume
- 7.70K
No earnings-call transcripts are available for PWS yet.
- Free Float
- 0.0%
- Shares Outstanding
- 750.01K
- Float Shares
- 0
of shares held by institutions
13 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Napa Wealth Management | 294.18K | ▲ 108.83K |
| Lpl Financial LLC | 105.15K | ▲ 277 |
| Org Wealth Partners, LLC | 68.81K | ▲ 1.59K |
| Org Partners LLC | 42.98K | ▼ 321 |
| Envestnet Asset Management Inc | 41.55K | ▲ 8.89K |
| Cetera Investment Advisers | 37.48K | ▲ 8.88K |
| Mather Group, LLC. | 28.94K | ▼ 174.30K |
| Concurrent Investment Advisors, LLC | 19.00K | ▼ 579 |
| Royal Bank Of Canada | 18.58K | ▼ 26.36K |
| Atria Investments, Inc | 12.70K | ▲ 203 |
| Allworth Financial LP | 2.72K | 0 |
| Morgan Stanley | 1 | ▲ 1 |
Our PWS coverage
Recent articles, reports, and earnings notes.
No research on PWS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PWS report →AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
gurufocus.com · Sep 28
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
gurufocus.com · Sep 28
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action
gurufocus.com · Sep 21
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
gurufocus.com · Sep 7
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadline
gurufocus.com · Sep 1
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
gurufocus.com · Aug 28
AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
gurufocus.com · Aug 16
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
globenewswire.com · Jun 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.